Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03073070 · ClinicalTrials.gov registry record · Phase 1
RBC Lifespan Measurement in Diabetic Children
A Phase 1 study of Diabetes and Red Blood Cell Survival, sponsored by Guohua An.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT03073070: Completed Phase 1 study of Diabetes and Red Blood Cell Survival, sponsored by Guohua An.
NCT03073070 is a Phase 1 study of Diabetes and Red Blood Cell Survival that has completed, run by Guohua An. The registered enrollment target is 6 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03073070, a Phase 1 study of Diabetes and Red Blood Cell Survival, has completed, sponsored by Guohua An.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
HbA1c, a measure of mean blood glucose over the lifespan of a red blood cell (RBC), is a marker of increasing importance both for assessing glycemic control in children with known diabetes and for the diagnosis of diabetes in children. HbA1c has demonstrated poor reliability in diagnosis and management of pediatric diabetes and the most plausible reason for this unreliability is that the reference ranges of HbA1c were established based on 120-day RBC lifespan observed in adults, without considering the RBC lifespan difference between children and adults. The proposed studies will for the first time determine RBC lifespan in diabetic children
Primary Outcome
the lifespan of red blood cells in children with diabetes
Conditions Studied
Interventions
- DRUG biotin labeled RBCs
Study Locations (1)
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2017-11-15 |
| Est. Completion | 2019-09-15 |
| Phase | Phase 1 |
What the finished NCT03073070 record still lists
NCT03073070 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which biotin labeled RBCs is the first listed.
NCT03073070 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT03073070 about?
NCT03073070 is a clinical study titled "RBC Lifespan Measurement in Diabetic Children". HbA1c, a measure of mean blood glucose over the lifespan of a red blood cell (RBC), is a marker of increasing importance both for assessing glycemic control in children with known diabetes and for the diagnosis of diabetes in children. HbA1c has demonstrated poor reliability in diagnosis and managem...
What is the current status of trial NCT03073070?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2017-11-15. Estimated completion is 2019-09-15.
What conditions does trial NCT03073070 study?
This clinical trial studies the following conditions: Diabetes, Red Blood Cell Survival.
What interventions are being tested in trial NCT03073070?
The interventions under investigation include: biotin labeled RBCs (DRUG).
Who is sponsoring clinical trial NCT03073070?
This trial is sponsored by Guohua An, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03073070 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03073070's enrollment target sits among peer trials
6 335th of 338 higher than 3 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mitigating the Pro-inflammatory Phenotype of Obesity
RECRUITING · Phase 1
-
Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye
RECRUITING · Phase 1
-
Insulin Balanced Infusion System
ACTIVE NOT RECRUITING · Phase 1
-
Ability of a Tea Leaf Extracts Preparation to Slow Down Carbohydrate and Fat Absorption
COMPLETED · Phase 1
-
Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections
COMPLETED · Phase 1
-
Family Management of Childhood Diabetes Study
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI